Article info
PDFOriginal research
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients
- Correspondence to Yanrong Ye, Department of pharmacy, Zhongshan Hospital Fudan University, Shanghai, Shanghai, China; yeyanrong1990{at}163.com; Mr Yun Shen; shen.yun{at}zs-hospital.sh.cn
Citation
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients
Publication history
- Received February 7, 2022
- Accepted April 5, 2022
- First published April 27, 2022.
Online issue publication
February 22, 2024
Article Versions
- Previous version (27 April 2022).
- You are viewing the most recent version of this article.
- latest version (22 February 2024).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2024. No commercial re-use. See rights and permissions. Published by BMJ.